NASA's Twins Study investigators met in Houston this week to discuss findings from the final data collections.
At the annual conference of the European Society of Human Genetics tomorrow (Saturday), Anya Prince, J.D. M.P.P., a postdoctoral research associate at the Centre for Genomics and Society, University of North Carolina, Chapel Hill, USA, will present results of her study comparing the regulation of life insurers' use of genetic information in the UK, Canada, and Australia.
Induced pluripotent stem cells (IPSCs) hold great promise in regenerative medicine, personalized medicine and drug discovery. However, while avoiding the ethical controversies associated with embryonic stem cells, they carry neoplastic risk owing to the use of the oncogenes c-Myc and Lin28. This has limited their utility in the biomedical arena.
Today, in the New England Journal of Medicine, the team from University Health Network in Toronto that developed the organization's protocol for medical assistance in dying (MAiD) describes UHN's approach and experience. This comes a year after Canada decriminalized medically assisted dying throughout the country.
Research suggests non-invasive post-mortem should become future standard first-line test in natural death.
Mothers are viewed negatively if their child hasn't been vaccinated, no matter the reason. But mothers who outright refuse to vaccinate their children are viewed in a harsher light compared to those who delay vaccines because of safety concerns or who aren't up to date due to time constraints.
A new study shows that the likelihood of health insurance reimbursement for some common clinical services differs significantly depending on whether they are provided by a complementary healthcare service provider or a primary care physician.
Physicians, parents and coaches should be cautious when considering treating injured young athletes with platelet rich plasma (PRP), stem cells or other types of regenerative medicine, says a nationally recognized sports medicine clinician and researcher at the University of Miami Miller School of Medicine and UHealth Sports Medicine Institute.
A first-ever global study finds massive inequity of access to and quality of health care among and within countries, and concludes people are dying from causes with well-known treatments.
A recent study finds that 'moral enhancement technologies' -- which are discussed as ways of improving human behavior -- are neither feasible nor wise, based on an assessment of existing research into these technologies.